The funds deployed to EMSCO Scientific are the first to be invested from the Innovate Capital Growth Fund, a fund launched in 2022 by the Enterprise Center to deploy capital to minority- and women-led businesses.
The Wistar Institute Announces the Appointment of Aleister Saunders, Ph.D., and Patrick Oates, Ph.D., to its Board of Trustees
Dr. Patrick Oates is the Senior Vice President of Business Development & Strategic Planning for EMSCO Scientific, Inc., where he manages partnerships with pharmaceutical companies and other life science entities to foster commercial growth.




